ConductScience.org, home

Paper656355

Long-term hypotensive effect of atenolol 4% eyedrops.

Brenkman RF. Br J Ophthalmol, 1978. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Long-term hypotensive effect of atenolol 4% eyedrops. Papers, record 656355. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/656355

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Long-term hypotensive effect of atenolol 4% eyedrops.
PubMed
Journal
Br J Ophthalmol
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
1.97
iCite
Revised in PubMed
2019-05-01
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Brenkman RFR F

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AtenololMajor topic
Intraocular PressureMajor topic
PropanolaminesMajor topic
Adult
Aged
Dose-Response Relationship, Drug
Drug Therapy, Combination
Epinephrine
Female
Glaucoma
Humans
Male
Middle Aged
Miotics
Ophthalmic Solutions
Time Factors

Source PubMed

Download CSV of topics

References9

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16021164Propranolol as ocular hypotensive agent.Br J Ophthalmol1967https://conductscience.org/library/papers/6021164PubMed
212782Atenolol versus propranolol. A comparison of ocular hypotensive effect of an oral dose.Br J Ophthalmol1976https://conductscience.org/library/papers/12782PubMed
34145269Practolol (Eraldin) eye drops as an ocular hypotensive agent.Br J Ophthalmol1973https://conductscience.org/library/papers/4145269PubMed
44392108Effect of DL- and D-propranolol on oscular tension in rabbits and patients.Exp Eye Res1970https://conductscience.org/library/papers/4392108PubMed
55572510A comparison of the ocular hypotensive actions of salbutamol and adrenaline in chronic simple glaucoma.Postgrad Med J1971https://conductscience.org/library/papers/5572510PubMed
6240378Ocular hypotensive effect of atenolol (Tenormin, I.C.I.). A new beta-adrenergic blocker.Br J Ophthalmol1975https://conductscience.org/library/papers/240378PubMed
7235443Proceedings: Adrenergic tachyphylaxis in animal and human eyes.Exp Eye Res1975https://conductscience.org/library/papers/235443PubMed
8952801Pathology of practolol-induced ocular toxicity.Br J Ophthalmol1976https://conductscience.org/library/papers/952801PubMed
91282Effect of oral administration of various beta-blocking agents on the intraocular pressure in healthy volunteers.Exp Eye Res1975https://conductscience.org/library/papers/1282PubMed

Download CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
7398531Atenolol 4% eyedrops in glaucoma simplex.Doc Ophthalmol1980https://conductscience.org/library/papers/7398531PubMed
7042481A dose-response study of oral atenolol administered once daily in patients with raised intra-ocular pressure.Graefes Arch Clin Exp Ophthalmol1982https://conductscience.org/library/papers/7042481PubMed
6351901Comparison of ocular hypotensive effects of 3 dosages of oral atenolol.Br J Ophthalmol1983https://conductscience.org/library/papers/6351901PubMed
2856892Effect of orally administered nadolol on the intraocular pressure in normal volunteers.Br J Ophthalmol1985https://conductscience.org/library/papers/2856892PubMed
1351412Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.Drugs Aging1992https://conductscience.org/library/papers/1351412PubMed
369807Timolol: a review of its therapeutic efficacy in the topical treatment of glaucoma.Drugs1979https://conductscience.org/library/papers/369807PubMed
38956The treatment of glaucoma: role of beta-blocking agents.Drugs1979https://conductscience.org/library/papers/38956PubMed
37770[The effect of timolol and parasympathicomimetica in the treatment of the elevated intraocular pressure (author's transl)].Albrecht Von Graefes Arch Klin Exp Ophthalmol1979https://conductscience.org/library/papers/37770PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/656355

GET https://conductscience.org/api/papers/v1/656355/authors